Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Cognition: the ultimate brain function.

Robbins TW.

Neuropsychopharmacology. 2011 Jan;36(1):1-2. doi: 10.1038/npp.2010.171. No abstract available.

2.

Gut feelings about irritable bowel syndrome.

Stahl SM.

J Clin Psychiatry. 2001 Aug;62(8):590-1. No abstract available.

3.

The sigma enigma: can sigma receptors provide a novel target for disorders of mood and cognition?

Stahl SM.

J Clin Psychiatry. 2008 Nov;69(11):1673-4. No abstract available.

4.

Cognitive enhancers: potential strategies and experimental results.

Wenk GL, Olton DS.

Prog Neuropsychopharmacol Biol Psychiatry. 1989;13 Suppl:S117-39. Review.

PMID:
2694226
5.

Intracellular signalling pathways and mood disorders.

Fišar Z, Hroudová J.

Folia Biol (Praha). 2010;56(4):135-48. Review.

6.

Affective cognition and its disruption in mood disorders.

Elliott R, Zahn R, Deakin JF, Anderson IM.

Neuropsychopharmacology. 2011 Jan;36(1):153-82. doi: 10.1038/npp.2010.77. Epub 2010 Jun 23. Review.

7.

Acetyl-L-carnitine and alpha-lipoic acid: possible neurotherapeutic agents for mood disorders?

Soczynska JK, Kennedy SH, Chow CS, Woldeyohannes HO, Konarski JZ, McIntyre RS.

Expert Opin Investig Drugs. 2008 Jun;17(6):827-43. doi: 10.1517/13543784.17.6.827 . Review.

PMID:
18491985
8.

Psychotomimetic effects of kappa opioid receptor agonists.

White KL, Roth BL.

Biol Psychiatry. 2012 Nov 15;72(10):797-8. doi: 10.1016/j.biopsych.2012.08.014. No abstract available.

PMID:
23083945
9.

Animal models of cognitive function.

Decker MW.

Crit Rev Neurobiol. 1995;9(4):321-43. Review.

PMID:
8829849
11.

The reward system of the brain.

Routtenberg A.

Sci Am. 1978 Nov;239(5):154-64. No abstract available.

PMID:
32618
12.

Neuropharmacological modulation of cognition.

Chamberlain SR, Müller U, Robbins TW, Sahakian BJ.

Curr Opin Neurol. 2006 Dec;19(6):607-12. Review.

PMID:
17102701
13.

Strains of rodents and the pharmacology of learning and memory.

Ammassari-Teule M, Castellano C.

Neural Plast. 2004;11(3-4):205-16. Review.

14.

The Role of Muscarinic Receptors in the Pathophysiology of Mood Disorders: A Potential Novel Treatment?

Jeon WJ, Dean B, Scarr E, Gibbons A.

Curr Neuropharmacol. 2015;13(6):739-49. Review.

15.

Neuroscience of addiction.

Koob GF, Sanna PP, Bloom FE.

Neuron. 1998 Sep;21(3):467-76. Review. No abstract available.

16.
17.

Using genetic data in cognitive neuroscience: from growing pains to genuine insights.

Green AE, Munafò MR, DeYoung CG, Fossella JA, Fan J, Gray JR.

Nat Rev Neurosci. 2008 Sep;9(9):710-20. doi: 10.1038/nrn2461. Review.

PMID:
19143051
18.

The emotional brain: combining insights from patients and basic science.

Rosen HJ, Levenson RW.

Neurocase. 2009 Jun;15(3):173-81. doi: 10.1080/13554790902796787.

19.

Affective neuroscience and psychiatry.

Harrison NA, Critchley HD.

Br J Psychiatry. 2007 Sep;191:192-4.

20.

Targeting tryptophan hydroxylase 2 in affective disorder.

Popova NK, Kulikov AV.

Expert Opin Ther Targets. 2010 Nov;14(11):1259-71. doi: 10.1517/14728222.2010.524208. Review.

PMID:
20874521

Supplemental Content

Support Center